loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of Certificates of Suitability (CEPs) for r0_cep_2006_068___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Smithkline Beecham Pharmaceuticals Irvine GB (1)

filter

01 Potassium clavulanate, diluted, silica, colloidal hydrated in a ratio 1:1 (1)

filter

01 United Kingdom (1)

filter

01 Withdrawn by Holder (1)

URL Supplier Web Content
R0-CEP 2006-068 - Rev 01
Withdrawn by Holder
Chemical
2010-02-02
2011-03-28
1653
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for Certificates of Suitability (CEPs) for R0-CEP 2006-068 - Rev 01 of Smithkline Beecham Pharmaceuticals Irvine Gb

Looking for Certificates of Suitability (CEPs) for R0-CEP 2006-068 - Rev 01 of Smithkline Beecham Pharmaceuticals Irvine Gb 1

20

Smithkline Beecham Pharmaceuticals Irvine Gb, based in United Kingdom, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their significant offerings is Potassium clavulanate, diluted, silica, colloidal hydrated in a ratio 1:1, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2006-068 - Rev 01

This Chemical Type CEP, issued on February 02, 2010, remains in force until March 28, 2011, ensuring its reliability within the pharmaceutical industry.

Substance Number 1653 associated with this CEP further emphasizes

Post Enquiry
POST ENQUIRY